SPDR ETFs Europe II plc - SPDR STOXX Europe 600 SRI UCITS ETF (ETR:ZPDX)
Germany
· Delayed Price · Currency is EUR 31.27
+0.61 (1.97%)
Apr 23, 2025, 5:36 PM CET
5.50% (1Y)
| Assets | 361.38M |
| Expense Ratio | 0.12% |
| PE Ratio | 17.21 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +5.53% |
| Volume | 11,701 |
| Open | 31.08 |
| Previous Close | 30.67 |
| Day's Range | 31.08 - 31.38 |
| 52-Week Low | 28.08 |
| 52-Week High | 33.79 |
| Beta | 0.97 |
| Holdings | 201 |
| Inception Date | Sep 30, 2019 |
About ZPDX
600X.AS was created on 2019-09-30 by SPDR. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 349.86m in AUM and 202 holdings. The investment objective of the Fund is to track the performance of European equities.
Asset Class Equity
Category Total Market
Stock Exchange Deutsche Börse Xetra
Ticker Symbol ZPDX
Provider SPDR
Index Tracked STOXX Europe 600 ESG-X Index
Performance
ZPDX had a total return of 5.53% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.30%.
Top 10 Holdings
35.77% of assets| Name | Symbol | Weight |
|---|---|---|
| SAP SE | SAP | 4.55% |
| Nestlé S.A. | NESN | 4.48% |
| ASML Holding N.V. | ASML | 4.36% |
| Roche Holding AG | ROG | 3.91% |
| AstraZeneca PLC | AZN | 3.81% |
| Novartis AG | NOVN | 3.68% |
| Novo Nordisk A/S | NOVO.B | 3.67% |
| Unilever PLC | ULVR | 2.59% |
| Allianz SE | ALV | 2.48% |
| Deutsche Telekom AG | DTE | 2.26% |